CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 24 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,467 | +28.6% | 19,824 | 0.0% | 0.00% | – |
| Q2 2023 | $29,141 | -24.6% | 19,824 | 0.0% | 0.00% | – |
| Q1 2023 | $38,656 | -6.3% | 19,824 | +8.1% | 0.00% | – |
| Q4 2022 | $41,274 | -8.3% | 18,344 | 0.0% | 0.00% | – |
| Q3 2022 | $45,000 | +18.4% | 18,344 | 0.0% | 0.00% | – |
| Q2 2022 | $38,000 | -34.5% | 18,344 | -11.0% | 0.00% | – |
| Q1 2022 | $58,000 | -39.6% | 20,617 | 0.0% | 0.00% | – |
| Q4 2021 | $96,000 | +74.5% | 20,617 | +2.0% | 0.00% | – |
| Q3 2021 | $55,000 | -5.2% | 20,221 | 0.0% | 0.00% | – |
| Q2 2021 | $58,000 | -6.5% | 20,221 | 0.0% | 0.00% | – |
| Q1 2021 | $62,000 | -3.1% | 20,221 | -6.9% | 0.00% | – |
| Q4 2020 | $64,000 | -13.5% | 21,715 | -5.5% | 0.00% | – |
| Q3 2020 | $74,000 | -3.9% | 22,974 | -0.2% | 0.00% | – |
| Q2 2020 | $77,000 | -14.4% | 23,018 | -7.0% | 0.00% | – |
| Q1 2020 | $90,000 | -29.7% | 24,748 | 0.0% | 0.00% | – |
| Q4 2019 | $128,000 | -12.9% | 24,748 | 0.0% | 0.00% | – |
| Q3 2019 | $147,000 | -8.1% | 24,748 | -1.5% | 0.00% | – |
| Q2 2019 | $160,000 | +4.6% | 25,113 | -4.6% | 0.00% | – |
| Q1 2019 | $153,000 | -6.7% | 26,329 | -3.3% | 0.00% | – |
| Q4 2018 | $164,000 | +5.1% | 27,227 | 0.0% | 0.00% | – |
| Q3 2018 | $156,000 | +4.0% | 27,227 | +11.5% | 0.00% | – |
| Q2 2018 | $150,000 | -5.7% | 24,429 | +3.0% | 0.00% | – |
| Q1 2018 | $159,000 | -13.1% | 23,723 | -4.6% | 0.00% | – |
| Q4 2017 | $183,000 | +7.0% | 24,875 | +2.5% | 0.00% | – |
| Q3 2017 | $171,000 | -5.0% | 24,264 | -5.7% | 0.00% | – |
| Q2 2017 | $180,000 | +1.1% | 25,726 | 0.0% | 0.00% | – |
| Q1 2017 | $178,000 | +18.7% | 25,726 | -6.2% | 0.00% | – |
| Q4 2016 | $150,000 | +16.3% | 27,427 | +6.0% | 0.00% | – |
| Q3 2016 | $129,000 | +12.2% | 25,865 | +1.5% | 0.00% | – |
| Q2 2016 | $115,000 | -24.8% | 25,478 | -25.2% | 0.00% | – |
| Q1 2016 | $153,000 | +62.8% | 34,067 | +90.5% | 0.00% | – |
| Q4 2015 | $94,000 | -9.6% | 17,885 | 0.0% | 0.00% | – |
| Q3 2015 | $104,000 | -22.4% | 17,885 | -4.9% | 0.00% | – |
| Q2 2015 | $134,000 | -13.5% | 18,801 | -19.2% | 0.00% | – |
| Q1 2015 | $155,000 | +4.7% | 23,256 | -5.9% | 0.00% | – |
| Q4 2014 | $148,000 | +22.3% | 24,706 | +1.0% | 0.00% | – |
| Q3 2014 | $121,000 | +11.0% | 24,458 | +0.8% | 0.00% | – |
| Q2 2014 | $109,000 | -2.7% | 24,271 | -2.1% | 0.00% | – |
| Q1 2014 | $112,000 | -11.1% | 24,793 | 0.0% | 0.00% | – |
| Q4 2013 | $126,000 | +12.5% | 24,793 | -0.4% | 0.00% | – |
| Q3 2013 | $112,000 | -81.1% | 24,893 | -78.5% | 0.00% | – |
| Q2 2013 | $592,000 | – | 115,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 896,170 | $4,615,000 | 3.22% |
| Ariel Investments | 1,010,220 | $5,203,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,000 | $942,000 | 0.01% |
| Anfield Capital Management, LLC | 4,530 | $23,000 | 0.01% |
| Financial Gravity Asset Management, Inc. | 2,000 | $10,000 | 0.01% |
| Oakworth Capital, Inc. | 3,052 | $16,000 | 0.00% |
| BAILARD, INC. | 11,816 | $61,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 860,319 | $4,431,000 | 0.00% |
| Renaissance Technologies | 469,338 | $2,417,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 98,192 | $506,000 | 0.00% |